ID   B3GL2_HUMAN             Reviewed;         500 AA.
AC   Q8NCR0; Q59GR3; Q5TCI3; Q96AL7;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 122.
DE   RecName: Full=UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2;
DE            Short=Beta-1,3-GalNAc-T2;
DE            EC=2.4.1.-;
DE   AltName: Full=Beta-1,3-N-acetylgalactosaminyltransferase II;
GN   Name=B3GALNT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Mammary gland, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 74-500 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, GLYCOSYLATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14724282; DOI=10.1074/jbc.M310614200;
RA   Hiruma T., Togayachi A., Okamura K., Sato T., Kikuchi N., Kwon Y.D.,
RA   Nakamura A., Fujimura K., Gotoh M., Tachibana K., Ishizuka Y.,
RA   Noce T., Nakanishi H., Narimatsu H.;
RT   "A novel human beta1,3-N-acetylgalactosaminyltransferase that
RT   synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc.";
RL   J. Biol. Chem. 279:14087-14095(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, VARIANTS MDDGA11 GLU-247; GLY-252;
RP   MET-268 AND PRO-292, AND CHARACTERIZATION OF VARIANTS MDDGA11 GLU-247;
RP   MET-268 AND PRO-292.
RX   PubMed=23453667; DOI=10.1016/j.ajhg.2013.01.016;
RG   UK10K Consortium;
RA   Stevens E., Carss K.J., Cirak S., Foley A.R., Torelli S., Willer T.,
RA   Tambunan D.E., Yau S., Brodd L., Sewry C.A., Feng L., Haliloglu G.,
RA   Orhan D., Dobyns W.B., Enns G.M., Manning M., Krause A., Salih M.A.,
RA   Walsh C.A., Hurles M., Campbell K.P., Manzini M.C., Stemple D.,
RA   Lin Y.Y., Muntoni F.;
RT   "Mutations in B3GALNT2 cause congenital muscular dystrophy and
RT   hypoglycosylation of alpha-dystroglycan.";
RL   Am. J. Hum. Genet. 92:354-365(2013).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23929950; DOI=10.1126/science.1239951;
RA   Yoshida-Moriguchi T., Willer T., Anderson M.E., Venzke D., Whyte T.,
RA   Muntoni F., Lee H., Nelson S.F., Yu L., Campbell K.P.;
RT   "SGK196 is a glycosylation-specific O-mannose kinase required for
RT   dystroglycan function.";
RL   Science 341:896-899(2013).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-203.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Beta-1,3-N-acetylgalactosaminyltransferase that
CC       synthesizes a unique carbohydrate structure, GalNAc-beta-1-
CC       3GlcNAc, on N- and O-glycans. Has no galactose nor galactosaminyl
CC       transferase activity toward any acceptor substrate. Involved in
CC       alpha-dystroglycan (DAG1) glycosylation: acts coordinately with
CC       GTDC2/POMGnT2 to synthesize a GalNAc-beta3-GlcNAc-beta-terminus at
CC       the 4-position of protein O-mannose in the biosynthesis of the
CC       phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-
CC       beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a
CC       carbohydrate structure present in alpha-dystroglycan, which is
CC       required for binding laminin G-like domain-containing
CC       extracellular proteins with high affinity.
CC       {ECO:0000269|PubMed:14724282, ECO:0000269|PubMed:23453667,
CC       ECO:0000269|PubMed:23929950}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine + N-acetyl-
CC       beta-D-glucosaminyl-(1->4)-O-alpha-D-mannosylprotein = UDP + N-
CC       acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-
CC       (1->4)-O-alpha-D-mannosylprotein. {ECO:0000269|PubMed:23929950}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.4 uM for UDP-GalNAc {ECO:0000269|PubMed:14724282};
CC         KM=11 mM for GlcNAc-beta-Bn {ECO:0000269|PubMed:14724282};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}. Endoplasmic
CC       reticulum {ECO:0000269|PubMed:23453667}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NCR0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NCR0-2; Sequence=VSP_020250, VSP_020251, VSP_020252;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined, but at
CC       highest levels in testis, adipose tissue, skeletal muscle and
CC       ovary. {ECO:0000269|PubMed:14724282}.
CC   -!- PTM: N-glycosylated. {ECO:0000305|PubMed:14724282}.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       brain and eye anomalies A11 (MDDGA11) [MIM:615181]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with cobblestone lissencephaly and other brain
CC       anomalies, eye malformations, profound mental retardation, and
CC       death usually in the first years of life. Included diseases are
CC       the more severe Walker-Warburg syndrome and the slightly less
CC       severe muscle-eye-brain disease. {ECO:0000269|PubMed:23453667}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16974.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL135928; CAI21727.1; -; Genomic_DNA.
DR   EMBL; AL135928; CAI21728.1; -; Genomic_DNA.
DR   EMBL; BC016974; AAH16974.1; ALT_INIT; mRNA.
DR   EMBL; BC029564; AAH29564.1; -; mRNA.
DR   EMBL; AB209046; BAD92283.1; -; mRNA.
DR   CCDS; CCDS1606.1; -. [Q8NCR0-1]
DR   CCDS; CCDS60453.1; -. [Q8NCR0-2]
DR   RefSeq; NP_001264084.1; NM_001277155.2. [Q8NCR0-2]
DR   RefSeq; NP_689703.1; NM_152490.4. [Q8NCR0-1]
DR   UniGene; Hs.498143; -.
DR   ProteinModelPortal; Q8NCR0; -.
DR   BioGrid; 127169; 13.
DR   IntAct; Q8NCR0; 1.
DR   STRING; 9606.ENSP00000355559; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   iPTMnet; Q8NCR0; -.
DR   PhosphoSitePlus; Q8NCR0; -.
DR   DMDM; 74751196; -.
DR   EPD; Q8NCR0; -.
DR   MaxQB; Q8NCR0; -.
DR   PaxDb; Q8NCR0; -.
DR   PeptideAtlas; Q8NCR0; -.
DR   PRIDE; Q8NCR0; -.
DR   TopDownProteomics; Q8NCR0-2; -. [Q8NCR0-2]
DR   DNASU; 148789; -.
DR   Ensembl; ENST00000313984; ENSP00000315678; ENSG00000162885. [Q8NCR0-2]
DR   Ensembl; ENST00000366600; ENSP00000355559; ENSG00000162885. [Q8NCR0-1]
DR   Ensembl; ENST00000635244; ENSP00000489219; ENSG00000282880. [Q8NCR0-2]
DR   Ensembl; ENST00000635453; ENSP00000489342; ENSG00000282880. [Q8NCR0-1]
DR   GeneID; 148789; -.
DR   KEGG; hsa:148789; -.
DR   UCSC; uc001hxc.4; human. [Q8NCR0-1]
DR   CTD; 148789; -.
DR   DisGeNET; 148789; -.
DR   GeneCards; B3GALNT2; -.
DR   HGNC; HGNC:28596; B3GALNT2.
DR   HPA; HPA012502; -.
DR   HPA; HPA050662; -.
DR   MalaCards; B3GALNT2; -.
DR   MIM; 610194; gene.
DR   MIM; 615181; phenotype.
DR   neXtProt; NX_Q8NCR0; -.
DR   OpenTargets; ENSG00000162885; -.
DR   Orphanet; 588; Muscle-eye-brain disease.
DR   Orphanet; 899; Walker-Warburg syndrome.
DR   PharmGKB; PA142672567; -.
DR   eggNOG; KOG2287; Eukaryota.
DR   eggNOG; ENOG410ZZ1B; LUCA.
DR   GeneTree; ENSGT00530000063810; -.
DR   HOGENOM; HOG000293391; -.
DR   HOVERGEN; HBG080884; -.
DR   InParanoid; Q8NCR0; -.
DR   KO; K09654; -.
DR   OMA; FYRWTVE; -.
DR   OrthoDB; EOG091G0TUV; -.
DR   PhylomeDB; Q8NCR0; -.
DR   TreeFam; TF314311; -.
DR   BRENDA; 2.4.1.313; 2681.
DR   Reactome; R-HSA-5173105; O-linked glycosylation.
DR   SABIO-RK; Q8NCR0; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; B3GALNT2; human.
DR   GenomeRNAi; 148789; -.
DR   PRO; PR:Q8NCR0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162885; -.
DR   CleanEx; HS_B3GALNT2; -.
DR   ExpressionAtlas; Q8NCR0; baseline and differential.
DR   Genevisible; Q8NCR0; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008378; F:galactosyltransferase activity; IEA:InterPro.
DR   GO; GO:0006486; P:protein glycosylation; IMP:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB.
DR   InterPro; IPR002659; Glyco_trans_31.
DR   PANTHER; PTHR11214; PTHR11214; 1.
DR   Pfam; PF01762; Galactosyl_T; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital muscular dystrophy; Disease mutation; Dystroglycanopathy;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Lissencephaly; Membrane; Polymorphism;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    500       UDP-GalNAc:beta-1,3-N-
FT                                acetylgalactosaminyltransferase 2.
FT                                /FTId=PRO_0000248362.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     23       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     24    500       Lumenal. {ECO:0000255}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      37     37       A -> AGGVSLLLPRLECNGAVSAHPNLHLPGSRDSPASAS
FT                                QVAGIT (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020250.
FT   VAR_SEQ     281    285       EGDAL -> GKFAS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020251.
FT   VAR_SEQ     286    500       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020252.
FT   VARIANT     203    203       N -> S (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035860.
FT   VARIANT     247    247       G -> E (in MDDGA11; affects subcellular
FT                                localization; dbSNP:rs367543072).
FT                                {ECO:0000269|PubMed:23453667}.
FT                                /FTId=VAR_069638.
FT   VARIANT     252    252       V -> G (in MDDGA11; dbSNP:rs367543073).
FT                                {ECO:0000269|PubMed:23453667}.
FT                                /FTId=VAR_069639.
FT   VARIANT     268    268       V -> M (in MDDGA11; affects subcellular
FT                                localization; dbSNP:rs367543074).
FT                                {ECO:0000269|PubMed:23453667}.
FT                                /FTId=VAR_069640.
FT   VARIANT     292    292       R -> P (in MDDGA11; does not affect
FT                                subcellular localization;
FT                                dbSNP:rs367543076).
FT                                {ECO:0000269|PubMed:23453667}.
FT                                /FTId=VAR_069641.
SQ   SEQUENCE   500 AA;  56704 MW;  F346C95857886026 CRC64;
     MRNWLVLLCP CVLGAALHLW LRLRSPPPAC ASGAGPADQL ALFPQWKSTH YDVVVGVLSA
     RNNHELRNVI RSTWMRHLLQ HPTLSQRVLV KFIIGAHGCE VPVEDREDPY SCKLLNITNP
     VLNQEIEAFS LSEDTSSGLP EDRVVSVSFR VLYPIVITSL GVFYDANDVG FQRNITVKLY
     QAEQEEALFI ARFSPPSCGV QVNKLWYKPV EQFILPESFE GTIVWESQDL HGLVSRNLHK
     VTVNDGGGVL RVITAGEGAL PHEFLEGVEG VAGGFIYTIQ EGDALLHNLH SRPQRLIDHI
     RNLHEEDALL KEESSIYDDI VFVDVVDTYR NVPAKLLNFY RWTVETTSFN LLLKTDDDCY
     IDLEAVFNRI VQKNLDGPNF WWGNFRLNWA VDRTGKWQEL EYPSPAYPAF ACGSGYVISK
     DIVKWLASNS GRLKTYQGED VSMGIWMAAI GPKRYQDSLW LCEKTCETGM LSSPQYSPWE
     LTELWKLKER CGDPCRCQAR
//
